本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

26.42
+0.78003.04%
成交量:38.97萬
成交額:1,028.78萬
市值:29.68億
市盈率:-15.51
高:26.74
開:26.04
低:25.91
收:25.64
52周最高:34.72
52周最低:15.96
股本:1.12億
流通股本:9,711.04萬
量比:0.34
換手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
淨資產收益率:-26.91%
總資產收益率:-14.75%
市淨率:4.89
市盈率(LYR):-16.49

資料載入中...

2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report